Connection
Marc Bonaca to Angiotensin Receptor Antagonists
This is a "connection" page, showing publications Marc Bonaca has written about Angiotensin Receptor Antagonists.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.090 |
|
|
|
-
Martins EB, Madrini V, Ramos Souza PV, Tavares CAM, Albuquerque MT, Santo KE, Harrington JA, Canonico ME, El Rafei A, Bonaca MP, Guimaraes PO. ANSWER-HF: sacubitril-valsartan reduces NT-proBNP in heart failure due to Chagas cardiomyopathy despite no reverse remodeling. Heart Fail Rev. 2026 03 23; 31(1).
Score: 0.056
-
Tea V, Bonaca M, Chamandi C, Iliou MC, Lhermusier T, Aissaoui N, Cayla G, Angoulvant D, Ferrières J, Schiele F, Simon T, Danchin N, Puymirat E. Appropriate secondary prevention and clinical outcomes after acute myocardial infarction according to atherothrombotic risk stratification: The FAST-MI 2010 registry. Eur J Prev Cardiol. 2019 03; 26(4):411-419.
Score: 0.034